Incident Report

Subform I: General Information

1. Report Type.

New incident report

Incident Report Number: 2008-5996

2. Registrant Information.

Registrant Reference Number: Prosar 1-16975587

Registrant Name (Full Legal Name no abbreviations): Syngenta Crop Protection Canada, Inc.

Address: 140 Research Lane, Research Park

City: Guelph

Prov / State: Ontario

Country: Canada

Postal Code: N1G4Z3

3. Select the appropriate subform(s) for the incident.

Human

4. Date registrant was first informed of the incident.

26-NOV-08

5. Location of incident.

Country: CANADA

Prov / State: ONTARIO

6. Date incident was first observed.

24-NOV-08

Product Description

7. a) Provide the active ingredient and, if available, the registration number and product name (include all tank mixes). If the product is not registered provide a submission number.

Active(s)

---

PMRA Registration No. 26153      PMRA Submission No.       EPA Registration No.

Product Name: Quadris Flowable Fungicide

• Active Ingredient(s)
  • AZOXYSTROBIN

---

7. b) Type of formulation.

Application Information

8. Product was applied?

Yes

9. Application Rate.

Unknown

10. Site pesticide was applied to (select all that apply).

Site: Agricultural-Indoor / Agricole-intérieur

Préciser le type: Rice plants

11. Provide any additional information regarding application (how it was applied, amount applied, the size of the area treated etc).

The product was applied to rice plants on the 2 days prior to the report.

To be determined by Registrant

12. In your opinion, was the product used according to the label instructions?

Unknown

Subform II: Human Incident Report (A separate form for each person affected)

1. Source of Report.

Data Subject

2. Demographic information of data subject

Sex: Female

Age: >19 <=64 yrs / >19 <=64 ans

3. List all symptoms, using the selections below.

System

• Respiratory System
  • Symptom - Runny nose

• General
  • Symptom - Malaise
  • Specify - "Weird feeling"

4. How long did the symptoms last?

<=30 min / <=30 min

5. Was medical treatment provided? Provide details in question 13.

No

6. a) Was the person hospitalized?

No

6. b) For how long?

7. Exposure scenario

Occupational

8. How did exposure occur? (Select all that apply)

Contact with treated area

9. If the exposure occured during application or re-entry, what protective clothing was worn? (select all that apply)

Unknown

10. Route(s) of exposure.

Skin

11. What was the length of exposure?

<=15 min / <=15 min

12. Time between exposure and onset of symptoms.

<=30 min / <=30 min

13. Provide any additional details about the incident (eg. description of the frequency and severity of the symptoms, type of medical treatment, results from medical tests, outcome of the incident, amount of pesticide exposed to, etc.)

1-169975587: A reporter called on 11/26/2008 to report her exposure to a fungicide containing the active ingredient Azoxystrobin. According to the reporter, she handled rice plants that had been treated with the product. The product was applied to the plants the past two days prior to the report (11/24/2008 and 11/25/2008). The reporter handled the plants following product application on each of these days, after the product had dried. The reporter was not the person applying the product to the plants. The reporter washed her hands after handling the plants and did not experience any dermal signs. The reporter stated that on 11/24/2008 and 11/25/2008, she developed nasal discharge that started immediately upon entering the room where the plants are kept. The nasal discharge resolved immediately upon exiting the room. The reporter also reported having a "weird feeling" while handling the plants on 11/24/2008, but she could not elaborate on this sign. The reporter was advised that the product is not expected to cause the signs described. The reporter was also advised that the product may cause signs of dermal irritation or redness following skin exposure. These signs should subside following irrigation and hand washing. A recommendation was made to review the Material Safety Data Sheet regarding safe handling of the product. No further information was obtained.

To be determined by Registrant

14. Severity classification.

Minor

15. Provide supplemental information here.

This is not a registered use for azoxystrobin, nor are the symptoms representative of exposure to this product.